Results of a randomized phase III trial of letrozole alone versus paclitaxel and carboplatin followed by letrozole as initial treatment for patients with stage II-IV ovarian, fallopian tube, or primary peritoneal low-grade serous carcinoma (NRG-GY019, NCT04095364)

Amanda Fader; Austin Miller; Lilian Gien; Amy Deery; Colleen Rivard; Lauren Cobb; Rachel Grisham; Laura Holman; Kidong Kim; Christa Nagel; Jessica Parker; Taymaa May; Erin Crane; Fernanda Musa; Sharad Ghamande; Shahzad Siddique; Richard Moore; Michael Goodheart; Premal Thaker; Theresa Werner; Lainie P. Martin; Erica Weston; Allan Covens; Carol Aghajanian; David Gershenson

doi:10.1016/j.ygyno.2026.02.023

Results of a randomized phase III trial of letrozole alone versus paclitaxel and carboplatin followed by letrozole as initial treatment for patients with stage II-IV ovarian, fallopian tube, or primary peritoneal low-grade serous carcinoma (NRG-GY019, NCT04095364)

Gynecologic Oncology 2026

View at publisher

Authors: Amanda Fader, Austin Miller, Lilian Gien, Amy Deery, Colleen Rivard, Lauren Cobb, Rachel Grisham, Laura Holman, Kidong Kim, Christa Nagel, Jessica Parker, Taymaa May

+13 more

Erin Crane, Fernanda Musa, Sharad Ghamande, Shahzad Siddique, Richard Moore, Michael Goodheart, Premal Thaker, Theresa Werner, Lainie P. Martin, Erica Weston, Allan Covens, Carol Aghajanian, David Gershenson

DOI: 10.1016/j.ygyno.2026.02.023

Cited by: 4

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment Estrogen and related hormone effects Intraperitoneal and Appendiceal Malignancies

Publication details

Journal / source: Gynecologic Oncology
Publisher: Elsevier BV
Volume: 208
Pages: S452–S452
Publication date: 23 April 2026
Language: EN